Ardelyx reported $148.62M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Abbott USD 52.06B 69M Mar/2026
Amgen USD 9.19B 532M Mar/2026
Ardelyx USD 148.62M 18.33M Mar/2026
aTyr Pharma USD 57.93M 82.05M Mar/2026
Corcept Therapeutics USD 637.99M 9.82M Mar/2026
Curis USD 5.46M 19.45M Dec/2025
Sanofi EUR 71.71B 14.25B Dec/2025
TG Therapeutics USD 583.13M 64.89M Mar/2026
United Therapeutics USD 5.9B 1.2B Mar/2026
Xoma USD 87.94M 15.5M Sep/2025